US FDA’s Fast Track Designation Policy Faces Unusual Legal Challenge

 
• By Brenda Sandburg
  
Fast track
US FDA sued for refusing to designate a drug for fast track process • Source: Shutterstock

More from US FDA

More from Agency Leadership